Corporate News Report – Talphera (TLPH) Market Performance
Trading Overview
During the 24‑hour trading window that concluded at 10:25 AM Central Europe on Wednesday, 21 October 2026, Talphera (ticker TLPH) exhibited a perfectly flat performance, recording a 0 % change. At the close of that session, a single share of Talphera was priced at USD 1.07 on the most widely used exchanges.
- Shares Outstanding: 51.9 million
- Market Capitalisation: USD 56.1 million
- 24‑Hour Volume: approximately USD 35 000 worth of shares were exchanged
- Month‑End Decline: a drop of –7.69 % has been observed since the close of the previous month
The 200‑day Simple Moving Average (SMA) sits at USD 1.01, placing the current price just above this long‑term trend line. Over the past year, Talphera’s 52‑week high was USD 1.57 (recorded on 24 November 2025), while the 52‑week low was USD 0.69 (on 7 April 2026).
Comparative Peer Activity
| Peer | 24‑Hour Performance | Current Price | Market Capitalisation | Notes |
|---|---|---|---|---|
| Research (RSSS) | 0 % | USD 1.98 | USD 65.3 million | PE ratio 22.41 |
| Maia Biotechnology (MAIA) | –2.73 % | USD 1.12 | USD 66.4 million | |
| Champions Oncology (CSBR) | –0.21 % | USD 4.81 | USD 65.4 million | |
| Neonc (NTHI) | +0.74 % | USD 2.77 | USD 67.1 million | |
| Charlottes Web (CWBHF) | +0.41 % | USD 0.26 | USD 67 million |
Talphera’s flat performance aligns it closely with its peer Research, while other companies in the same sector displayed modest gains or declines, highlighting the relative stability of the group in the immediate term.
Company Profile
Talphera, Inc. is a specialty pharmaceutical firm focused on the research, development, and commercialization of acute pain therapies intended for administration in medically supervised environments. The company’s product portfolio is tailored to patients requiring rapid pain relief, and it operates on a global scale. Talphera made its debut on the Nasdaq stock exchange on 14 February 2011 and has since cultivated a presence in the competitive field of pain management solutions. For more information, visit the company’s website at www.talphera.com .
